RxDoctor Payments Data

Corrie Ackerman, PA

Medical · Dunedin, FLNPI 1982706701

Payments from drug & device makers

$499in general payments, 2019–2025

Across 31 payments — averaging $16.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$132
  • Exact Sciences$68
  • Lilly USA, LLC$67
  • Pfizer$46
  • Boehringer Ingelheim$46
  • AstraZeneca$31
  • plus $109 from 6 others

What the payments were for

  • Food & beverage$499100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$499 in reported general payments places this provider in the 40th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida

Medicare billing

Part B allowed, 2024
$82,266
Medicare patients
495
Services billed
1,100

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide25$30,177
JardianceEmpagliflozin24$29,905
EliquisApixaban21$22,332
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$11,655
MounjaroTirzepatide11$11,372
FarxigaDapagliflozin Propanediol11$11,282
XareltoRivaroxaban12$10,658
Olmesartan Medoxomil71$1,181
Levothyroxine Sodium111$1,119
ValacyclovirValacyclovir Hcl14$1,109
Escitalopram Oxalate60$908
Ondansetron Hcl11$900
Metoprolol Succinate39$876
Methylprednisolone127$848
Amlodipine Besylate137$846

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$132$30,17725 claims
Boehringer IngelheimJardiance$46$29,90524 claims
PfizerEliquis$46$22,33221 claims
GSKTrelegy Ellipta$22$11,65518 claims
Lilly USA, LLCMounjaro$67$11,37211 claims
AstraZenecaFarxiga$31$11,28211 claims
AbbVieSynthroid$21$46011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 2,031 medical providers in Florida.

Other medical in Dunedin

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →